|Denaro||0,00 x 900|
|Lettera||0,00 x 800|
|Min-Max giorno||245,12 - 249,98|
|Intervallo di 52 settimane||144,00 - 275,87|
|Beta (5 anni mensile)||0,32|
|Rapporto PE (ttm)||37,84|
|Prossima data utili||03 feb 2022|
|Rendimento e dividendo (forward)||3,40 (1,37%)|
|Data ex dividendo||12 nov 2021|
|Stima target 1A||N/D|
Eli Lilly and Company, a pharmaceutical giant based in Indianapolis, is expected to report earnings of $1.93 per share, representing a year-over-year increase of over 2% from $1.89 per share a year ago.
Indianapolis-based pharmaceutical giant Eli Lilly and Company reported better-than-expected profit in the fourth quarter, led by solid demand for its cancer and diabetes drugs, sending its shares up over 4% in pre-market trading on Friday.